TETMedical continues development of NSE-FAST, the first in-vitro diagnostic blood test for brain injury from stroke, with clinical studies underway and FDA pivotal study planned for Summer 2026. Read more on TETMedical →
Mulberry has been named the exclusive jewelry care plan provider for Valliani Jewelers, deepening its retail protection partnerships.
Biotia's BIOTIA-DX Resistance is now clinically available, delivering rapid antimicrobial resistance profiling for UTI patients.
